Clinical Trial Update: SGLT2i, Hepatic Glucose Production, and SNS [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial from The University of Texas Health Science Center at San Antonio is evaluating how an SGLT2 inhibitor affects hepatic glucose pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type 2 Diabetes | EARLY_Phase 1 | Status: RECRUITING